Tamtam Try Tamtam free
Terveystalo logo

Terveystalo account plan

Health care services in Finland

At a glance

Terveystalo is Finland's largest private healthcare provider by revenue, with EUR 1,278.9 million FY2025 revenue and around 14,400 professionals.

Terveystalo provides primary care, specialised care, diagnostics, dental and wellbeing services in Finland to corporate clients, insurance companies, consumers and the public sector, through a clinic and hospital network, 24/7 digital appointments and an app with around 2.7 million registered users; in Sweden it runs occupational health through its subsidiary Feelgood. In 2025 it served approximately 2.1 million individual customers and recorded around 7.2 million customer visits in Finland. FY2025 revenue was EUR 1,278.9 million (-4.6%), adjusted EBIT EUR 156.3 million (12.2% of revenue) and the result for the period EUR 92.6 million; it employs around 14,400 professionals, many of them private practitioners rather than employees. It is listed on Nasdaq Helsinki (TTALO), with OP Financial Group the largest registered holder at 13.91% at the time of the annual report.

Business units

Strategic priorities

ARC strategy: from profitability to growth
The ARC strategy updated in June 2026 rests on customer centricity, broad use of technology and growth, with six objectives including scaling continuous digital services and reinventing corporate health. The CFO describes the shift as moving from optimising profitability to profitable, focused growth.
Occupational health turnaround
A two-year occupational health development programme (to 2027) renews service models, pricing transparency and production, with more than EUR 20 million to be invested over two years. Terveystalo is growing again with large accounts and expects connected employees to grow again in Q1 2027, while SMEs still show net churn.
Digital and AI productivity
The Digital Health 10x ambition targets up to a tenfold productivity increase through a modular API-based platform and AI automation of clinical and administrative tasks. The Ella patient information system is rolling out in 2025-2026, AI is integrated into clinical documentation, and the Leo occupational health platform rolls out in H1.
Retail-style packaged services
Terveystalo is moving to transparent, fixed-price packages in orthopedics, GP and gynecology (for example an orthopedic operation at EUR 11,000) and to continuous services such as the Wellby weight management pilot with monthly pricing.
Oral health and eye care growth
The goal is to become a leader in oral health after the Hohde deal doubled the dental business, and to become Finland's leading eye health player through Silmäasema. From 1 January 2027 reporting segments become Healthcare Services, Oral Health, Public Partnerships and Sweden.
New financial targets
Adjusted EPS growth of 10% a year on average, net debt to adjusted EBITDA of no more than 3x, and at least 50% of the net result distributed, down from at least 80%.

Latest results

In Q3 2026 (July-September) revenue fell 6.2% to EUR 262.9 million and adjusted EBIT fell 33.6% to EUR 17.8 million, 6.8% of revenue (9.5%), as weak demand hit all segments; the company issued a profit warning on 20 October 2026. For January-September 2026 revenue was EUR 864.4 million (-8.9%) and adjusted EBIT EUR 77.6 million (9.0% of revenue), with net debt at EUR 647.1 million and net debt/adjusted EBITDA at 2.9 after the Hohde deal. Occupational health customer revenue fell 9.9% in Q3 on fewer connected employees, low morbidity and smaller client contracts, while insurance grew 2.4% and dental care rose 54.2%. Guidance for 2026 adjusted EBIT was cut to EUR 110-120 million (July guidance EUR 120-140 million; 2025: EUR 156.3 million), and the demand environment is expected to stay challenging in Q4.

Investments and deals

Silmäasema acquisition
Agreement signed 8 June 2026 to buy Finland's leading eye care and optical chain for approximately EUR 574 million (EUR 275 million cash and 36.5 million new shares), with completion expected by end-2026 or Q1 2027. Silmäasema has 155 optical stores in Finland and 10 in Estonia; synergies of EUR 11 million-EUR 15 million annual run rate are targeted.
Hohde Group dental acquisition
Signed 23 December 2025 at an enterprise value of approximately EUR 88 million and completed 4 September 2026 after competition approval; the combined oral health business has 1,500 dental professionals, 63 clinics and 14 laboratories, with synergies of roughly EUR 4 million.
Solo Health Group
Agreement signed 4 September 2026 to buy a public-sector staffing provider of physician, nursing and psychologist services with over 700 professionals and 2025 revenue of EUR 33.1 million; completion expected in H1 2027.
Digital, IT and premises investment
Investments excluding M&A were EUR 121.3 million in 2025, mainly right-of-use assets (premises), digital application and service development, IT systems and medical equipment. Terveystalo also took an approximately 25% stake in a joint venture that acquired a majority of Swedish AI-based health platform MedHelp Care.
New bank financing
EUR 550 million of bank financing was signed in Q2 2026: EUR 200 million for Hohde and refinancing and EUR 350 million conditional on the Silmäasema deal; the revolving facility was raised to EUR 100 million.

Challenges and risks

Weak occupational health demand
Fewer connected occupational health customers, lower employment at clients, cost-driven tendering and SME churn cut volumes; occupational health is late-cyclical, so no great improvement was expected in the second half of 2026.
Negative operating leverage
Lower volumes in Q3 2026 dropped through to EBIT as fixed costs could not be cut at the pace of revenue; morbidity was about 15% below the prior year.
Public-sector savings
Wellbeing services counties remain focused on cost savings with mostly small targeted tenders; outsourcing revenue is expected to fall by approximately EUR 25 million in 2026.
Higher leverage and integration risk
Net debt/adjusted EBITDA reached 2.9 against a 3x target after Hohde, with the larger Silmäasema deal still to close; the risk list includes M&A, integration and regulatory approvals.
Staff, IT and regulatory risks
The annual report names recruiting and retaining healthcare professionals, dependence on information systems and external providers, cyber threats, and changes from the social and healthcare reform and reimbursement systems.

What leadership says

“All in all, a disappointing quarter from Terveystalo point of view”

Ville Iho, President and CEO · Terveystalo Q3 2026 results webcast, 21 October 2026

“We expect the number of connected employees to start growing again during the first quarter of 2027.”

Ville Iho, President and CEO · Terveystalo Q3 2026 results webcast, 21 October 2026

“By staying put in our current service portfolio and only sort of optimizing that one our conclusion was that it's not going to yield material value creation in the future.”

Ville Iho, President and CEO · Silmäasema acquisition and ARC strategy investor call, 8 June 2026

“In 2025, we reinforced Terveystalo's role as a healthcare reformer.”

Ville Iho, President and CEO · Terveystalo Annual Report 2025, published 27 February 2026

Where a supplier can help

Integration of Hohde and Silmäasema
Tied to the Hohde and Silmäasema acquisitions: roughly 70% of the Silmäasema synergies are cost synergies from network optimisation, procurement and shared digital capex, which opens room for suppliers of procurement, IT integration and network consolidation services.
AI and digital platform delivery
Tied to the Digital Health 10x priority and the Ella, Leo and AI documentation rollouts: vendors of clinical AI, API platforms, cybersecurity and data tools can support a company that lists IT and cyber dependence among its risks.
Selling occupational health to SMEs
Tied to the occupational health turnaround: SME services need repackaging to be easier to buy, use and pay for, which points to sales enablement, pricing and customer engagement tools.
Cost control under margin pressure
Tied to the negative operating leverage challenge and the cut 2026 guidance: offers that lower fixed costs in clinics, diagnostics or premises address a stated pain.
Retail and subscription models
Tied to the packaged-services priority: fixed-price packages and the Wellby monthly-priced continuous service need e-commerce, billing and consumer marketing capabilities.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Terveystalo?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Terveystalo

What does Terveystalo do?

Terveystalo is the largest private healthcare service provider in Finland by revenue, offering primary care, specialised care, diagnostics, occupational health, dental and wellbeing services through clinics, hospitals and digital channels. In Sweden it provides occupational health through Feelgood.

What is Terveystalo's revenue?

FY2025 revenue was EUR 1,278.9 million, down 4.6%, with adjusted EBIT of EUR 156.3 million. For January-September 2026 revenue was EUR 864.4 million (-8.9%).

How many people work at Terveystalo?

Around 14,400 professionals in 2025; at 30 September 2026 it had 8,111 employed staff and 6,268 non-employees, as most physicians are private practitioners.

What is Terveystalo's strategy?

The ARC strategy updated in June 2026 focuses on customer centricity, broad use of technology and growth, including transparent service packages, continuous digital services, an occupational health turnaround and growth in oral health and eye care through the Hohde and Silmäasema acquisitions.

Who leads Terveystalo?

Ville Iho is President and CEO. CFO Juuso Pajunen leaves on 15 December 2026; the Board is chaired by Kari Kauniskangas.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)